Choice Hotels reported third-quarter non-GAAP EPS of $2.33, beating estimates by $0.04, and revenue of $458 million. It raised its full-year 2026 outlook. IDEXX Laboratories' revenue grew 10% to $1.21 billion, surpassing analyst estimates, and it reported EPS of $3.96. IDEXX updated its 2026 revenue guidance; both companies raised their full-year outlooks after strong third-quarter performance.
The company reported revenue of $1.214 billion and diluted earnings per share of $4.01, but narrowed its projected operating margin range for the year.
Read the full storyComparable diluted EPS rose 22%, while the company lowered its full-year operating margin outlook despite raising its revenue range.
The company raised its full-year revenue and companion animal recurring diagnostics growth outlook, while shares rose 2.57% in premarket trading.
The company raised its 2026 revenue and earnings-per-share outlook while lowering its annual operating margin range, as recurring diagnostics continued to grow at different rates across markets.